Medlanes Company
Biosensor technologyLucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme calledLucentix - Crunchbase Company Profile & Fundingwww.crunchbase.com/organization/lucentixБыл ли этот ответ полезен?
Technology:
Other type
Headquarters:
Germany
Funding Status:
Early Stage Venture
Founded Date:
2013
Estimated Revenue:
$1M to $10M
Employee Number:
25
Industry:
Diagnostics and Prognostics
Investor Type:
For Profit